基于 2020 年 7 月至 2021 年 12 月期间的献血数据更新的美国感染和疫苗诱导的 SARS-CoV-2 血清流行率估计。
Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.
机构信息
COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
Westat, Rockville, Maryland.
出版信息
JAMA. 2022 Jul 19;328(3):298-301. doi: 10.1001/jama.2022.9745.
Abstract
This cross-sectional study examines monthly blood donations from individuals aged 16 years and older to estimate the population with antibodies to SARS-CoV-2 from infection or vaccination.
摘要
本横断面研究对 16 岁及以上个体的每月献血进行分析，以估算因感染或接种疫苗而具有 SARS-CoV-2 抗体的人群。
相似文献
1
Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.基于 2020 年 7 月至 2021 年 12 月期间的献血数据更新的美国感染和疫苗诱导的 SARS-CoV-2 血清流行率估计。
JAMA. 2022 Jul 19;328(3):298-301. doi: 10.1001/jama.2022.9745.
2
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.根据 2020 年 7 月至 2021 年 5 月的献血样本，估计美国感染和疫苗引起的 SARS-CoV-2 血清流行率。
JAMA. 2021 Oct 12;326(14):1400-1409. doi: 10.1001/jama.2021.15161.
3
Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021.2021 年 1 月至 12 月美国献血人群中，由严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染、疫苗接种和混合免疫引起的人群加权血清阳性率。
Clin Infect Dis. 2022 Oct 3;75(Suppl 2):S254-S263. doi: 10.1093/cid/ciac470.
4
Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era.疫苗时代加拿大献血者中 SARS-CoV-2 血清流行率的变化模式。
Microbiol Spectr. 2022 Apr 27;10(2):e0033922. doi: 10.1128/spectrum.00339-22. Epub 2022 Apr 12.
5
Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 2021.疫苗接种对法国献血者中SARS-CoV-2血清阳性率的影响：截至2021年7月的评估
Transfus Clin Biol. 2023 Feb;30(1):25-26. doi: 10.1016/j.tracli.2022.08.002. Epub 2022 Aug 5.
6
The evolution of COVID-19 vaccination within a US blood center.美国一家血液中心内新冠疫苗接种情况的演变
Transfusion. 2021 Sep;61(9):2528-2529. doi: 10.1111/trf.16579. Epub 2021 Jun 30.
7
Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status - United States, April 2021-September 2022.2021 年 4 月至 2022 年 9 月期间，按 COVID-19 疫苗接种状况划分的献血者中 SARS-CoV-2 血清流行率和原发性 SARS-CoV-2 感染发生率估计值-美国。
MMWR Morb Mortal Wkly Rep. 2023 Jun 2;72(22):601-605. doi: 10.15585/mmwr.mm7222a3.
8
Social Vulnerability and Rurality Associated With Higher Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection-Induced Seroprevalence: A Nationwide Blood Donor Study-United States, July 2020-June 2021.社会脆弱性和农村地区与更高的严重急性呼吸系统综合征冠状病毒 2（SARS-CoV-2）感染诱导的血清阳性率相关：2020 年 7 月至 2021 年 6 月美国全国献血者研究。
Clin Infect Dis. 2022 Aug 24;75(1):e133-e143. doi: 10.1093/cid/ciac105.
9
SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.加拿大第一波 COVID-19 疫情后献血者中的 SARS-CoV-2 血清流行率。
Transfusion. 2021 Mar;61(3):862-872. doi: 10.1111/trf.16296. Epub 2021 Feb 23.
10
Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022.2022 年日本献血者中因感染导致的 SARS-CoV-2 血清阳性率。
Emerg Infect Dis. 2023 Sep;29(9):1868-1871. doi: 10.3201/eid2909.230365. Epub 2023 Jul 28.
引用本文的文献
1
Comparison of Infection-Induced SARS-CoV-2 Seroprevalence Across Large-Scale Residual Samples From Blood Donors, Commercial Laboratories, and Health Checkups in Japan, 2023.2023年日本献血者、商业实验室和健康检查的大规模剩余样本中感染诱导的新冠病毒血清流行率比较
Open Forum Infect Dis. 2025 Jul 17;12(8):ofaf415. doi: 10.1093/ofid/ofaf415. eCollection 2025 Aug.
2
Integrated Analysis of the 2022 SARS-CoV-2 Omicron Lineage Replacement Dynamics in Connecticut, US.美国康涅狄格州2022年新冠病毒奥密克戎谱系替代动态的综合分析
Viruses. 2025 Jul 21;17(7):1020. doi: 10.3390/v17071020.
3
Seroprevalence Trends of Antibodies to SARS-CoV-2 in South Korea, 2021-2022: A Repeated Cross-Sectional Study.2021 - 2022年韩国新型冠状病毒抗体血清流行趋势：一项重复横断面研究
Influenza Other Respir Viruses. 2025 Jun;19(6):e70117. doi: 10.1111/irv.70117.
4
Detection of SARS-CoV-2 Reinfections Using Nucleocapsid Antibody Boosting.利用核衣壳抗体增强检测新型冠状病毒2型再感染
Emerg Infect Dis. 2025 May;31(5):958-966. doi: 10.3201/eid3105.250021.
5
Blood donor SARS-CoV-2 infection or vaccination and adverse outcomes in plasma and platelet transfusion recipients.献血者感染新型冠状病毒2（SARS-CoV-2）或接种疫苗与血浆和血小板输注受者的不良结局
Transfusion. 2025 Mar;65(3):485-495. doi: 10.1111/trf.18159. Epub 2025 Feb 26.
6
The disappearing COVID-Naïve Population and comparative Roche vs. Abbott Test sensitivity: evidence from antibody seroprevalence in Milwaukee County, Wisconsin.《消失的新冠病毒未感染人群与罗氏和雅培试剂检测敏感性比较：威斯康星州密尔沃基县抗体血清阳性率证据》。
Sci Rep. 2024 Nov 13;14(1):27850. doi: 10.1038/s41598-024-76946-1.
7
Adherence to COVID-19 vaccination recommendations and vaccine hesitancy in US blood donors.美国献血者对新冠疫苗接种建议的依从性及疫苗犹豫情况
Transfusion. 2024 Dec;64(12):2314-2324. doi: 10.1111/trf.18051. Epub 2024 Oct 21.
8
SARS-COV-2 breakthrough infection and its covariates among healthcare providers of a hospital in Bangladesh during the omicron wave.孟加拉国一家医院的医护人员在奥密克戎毒株流行期间的新冠病毒突破性感染及其相关因素。
Heliyon. 2024 Sep 2;10(17):e37287. doi: 10.1016/j.heliyon.2024.e37287. eCollection 2024 Sep 15.
9
Higher intraindividual variability of body mass index is associated with elevated risk of COVID-19 related hospitalization and post-COVID conditions.个体内体重指数变异较大与 COVID-19 相关住院和新冠后状况的风险增加相关。
Int J Obes (Lond). 2024 Dec;48(12):1711-1719. doi: 10.1038/s41366-024-01603-6. Epub 2024 Aug 12.
10
Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19.奈玛特韦/利托那韦口服作为新冠病毒暴露后预防。
N Engl J Med. 2024 Jul 18;391(3):224-234. doi: 10.1056/NEJMoa2309002.
Zotero 插件